PR Newswire PharmaOriginal article
A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
EarningsPositive
AI Analysis
Summary
CERS reported H1 2026 results with 7.4% organic revenue growth and adjusted EBIT margin of 18.8%, driven by gains in both companion animal (+10.0%) and farm animal (+6.7%) segments.
Financial Highlights
Revenue
+7.4% organic growth
Importance:3/10
Sentiment:
0.65
earningsrevenue_growthH1_2026_resultscompanion_animalfarm_animal
Related Companies
Read the original article
Published by PR Newswire Pharma on September 17, 2026 4:04 PM
